Nolato AB (LTS:0OA9) Other Financing: kr0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0OA9 Nolato AB LTS:0OA9
75 GF Score
Price kr49.13
GF Value kr54.38
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Nolato AB Other Financing?

Nolato AB LTS:0OA9 +0.18% 75 Other Financing is kr0 Mil as of Mar. 2026. GuruFocus rates LTS:0OA9 with a GF Score™ of 75/100 and a GF Value™ of kr54.38 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Nolato AB's Other Financing for the three months ended in Mar. 2026 was kr0 Mil.

Nolato AB's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was kr0 Mil.

Nolato AB Other Financing Historical Data

* Premium members only.

The historical data trend for Nolato AB's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nolato AB Other Financing Chart

Nolato AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -1.00 0.00 0.00 0.00

Nolato AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LTS:0OA9
75GF Score
Nolato AB LTS:0OA9
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nolato AB Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of kr0 Mil mean?
Nolato AB (LTS:0OA9) has a Other Financing of kr0 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Nolato AB and its competitors.
Is Nolato AB's Other Financing too high?
Nolato AB's current Other Financing is kr0 Mil. Overall, Nolato AB has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nolato AB's Other Financing compare to ABT and SYK?
Nolato AB's Other Financing of kr0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Medical Devices & Instruments company?
A good Other Financing depends on the Medical Devices & Instruments industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Nolato AB and its competitors. Nolato AB's current Other Financing is kr0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nolato AB stock overvalued right now?
Based on GuruFocus' analysis, Nolato AB (LTS:0OA9) is currently considered Modestly Undervalued. The stock's GF Value™ is kr54.38, compared to a current price of kr49.13 — trading 9.7% below its estimated fair value. The current Other Financing is kr0 Mil. Nolato AB's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Nolato AB (LTS:0OA9), the current Other Financing is kr0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nolato AB (LTS:0OA9) Overvalued in 2026?

Based on GuruFocus' analysis, Nolato AB stock appears to be undervalued. The current stock price of kr49.13 is trading 9.7% below its estimated GF Value™ of kr54.38. GuruFocus considers Nolato AB to be Modestly Undervalued.

Key valuation signals for LTS:0OA9:

  • Other Financing: kr0 Mil
  • GF Value™: kr54.38 vs. price of kr49.13 (9.7% below fair value)
  • GF Score™: 75/100 with 2 warning signs

No single metric tells the full story. See the LTS:0OA9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nolato AB Business Description

Address Nolatovagen 32, Torekov, SWE, SE-269 78
Nolato AB is a Swedish company that develops and manufactures plastic, silicone, and thermoplastic elastomer products. The firm's operations are organized into two segments: Medical Solutions and Engineered Solutions. The company generates the majority of its revenue from the Medical Solutions segment, which is engaged in the development and manufacture of complex product systems and components for medical devices, the pharmaceutical industry, and diagnostics. The Engineered Solutions design, development, industrialization, and manufacture of subsystems and ready-packaged products for a range of industries, including offerings within EMC and thermal solutions. Geographically, the firm generates key revenue from the Rest of Europe and the United States.
75GF Score

Get the complete analysis for LTS:0OA9

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr49.13
Price
kr54.38
GF Value